Full-Time

VP – Global Market Access

Posted on 4/23/2024

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops radiopharmaceuticals for oncology, rare diseases

Biotechnology

Senior

Remote in USA

Required Skills
Communications
Requirements
  • Advanced degree in health economics, health policy, Pharmacoeconomics, or a related field required
  • 10+ years of experience in global market access, reimbursement, or health economics, with a proven track record of success in developing and executing market access strategies
  • Deep understanding of the regulatory landscape for nuclear medical products
  • Good understanding of the US and EU Price & Reimbursement strategy
  • Strong leadership and interpersonal skills with a demonstrated ability to work collaboratively with cross-functional teams
  • Excellent communication and presentation skills
  • Strong analytical and strategic thinking abilities
  • Experience in the nuclear medical pharmaceutical industry is preferred
  • Ability to work effectively in a fast-paced and dynamic environment, balancing multiple priorities and meeting deadlines
Responsibilities
  • Develop and implement global market access strategies
  • Monitor and evaluate trends in healthcare policy, market access, and reimbursement environments
  • Contribute to the globalization of therapeutics to populations across new and emerging markets
  • Define pricing, tendering, contracting, and life-cycle strategies
  • Lead health economics and outcomes research
  • Inform price-setting through pricing research
  • Establish and maintain relationships with key stakeholders
  • Provide input into clinical development plans
  • Drive cross-functional collaboration

Telix Pharmaceuticals Limited is at the forefront of enhancing oncological and rare disease management through their specialized radiopharmaceuticals that aid both in diagnosis and therapy. The company's focus on developing targeted radiation products for a range of cancers - including prostate, kidney, brain, and hematologic types - ensures that they are a leader in personalized healthcare solutions. By securing global regulatory approvals and establishing a reliable supply chain, they offer a robust environment for professional growth and innovation within the pharmaceutical industry.

Company Stage

Grant

Total Funding

$63.5M

Headquarters

North Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

16%

1 year growth

44%

2 year growth

129%